✦ LIBER ✦

Salvage therapy with PROMACE in relapsed non-Hodgkin malignant lymphoma

✍ Scribed by Dr. Henrik Nielsen

Book ID: 114791434
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 155 KB
Volume: 46
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1991.tb00535.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Initial response to salvage therapy dete

Initial response to salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients

✍ Monika L. Metzger; Melissa M. Hudson; Matthew J. Krasin; Jianrong Wu; Sue C. Kas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB

Salvage therapy for relapsed or refracto

Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation

✍ Julie M. Vose; James O. Armitage; Philip J. Bierman; Dennis D. Weisenburger; Mar 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 502 KB

Salvage therapy with etoposide, ifosfami

Salvage therapy with etoposide, ifosfamide, methotrexate and bleomycin in non-hodgkin's lymphomas

✍ B. Steinke; F. W. Busch; M. Heim; H. Arnold 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 134 KB

Gemcitabine-Based Therapy in Relapsed No

Gemcitabine-Based Therapy in Relapsed Non-Hodgkin's Lymphoma and Cutaneous T-Cell Lymphoma

✍ Lee, David; Jain, Vinay K. 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 102 KB

Cladribine combined with rituximab (R-2-

Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma

✍ Hirokazu Nagai; Michinori Ogura; Shigeru Kusumoto; Naoto Takahashi; Motoko Yamag 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Radiotherapy as salvage treatment in pat

Radiotherapy as salvage treatment in patients with hodgkin's disease or non-hodgkin's lymphoma relapsing after initial chemotherapy

✍ Carine Kirkove; Adrian R. Timothy 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB

## Abstract The prognosis of relapsing Hodgkin's disease (HD) and high grade aggressive non‐Hodgkin's lymphoma (NHL) is generally poor since many of these patients fail to respond to second line chemotherapy. Radiation therapy has been reported as an effective but seldom used, alternative treatment